A Danish nationwide, prospective study shows that cytotoxic therapy are not associated with adverse outcomes of SARS-CoV-2 infection for patients with solid cancer. Whereas patients with progressive disease seem to be at greater risk of a fatal outcome from COVID-19.
Compared with younger persons, there is less evidence to guide treatment decisions for older persons with cancer, because this group is underrepresented in clinical trials. Older persons with cancer constitute a heterogeneous group, some being fit, some vulnerable, and some even frail. By now, geriatric assessment has not been implemented in oncologic care in Denmark.
|Kristian Kirkelund Bentsen will start as a PhD student and study outcomes and side effects to sterotactic body radiation therapy to older patients with lung cancer.|
|Article in "Tæt på kræft, Feb. 2020, Nr. 1" (click picture to view larger edition):|
|Helena Ditzel, the Department of Oncology, and Ann-Kirstine Weber Giger, The Geriatric Research Unit, will start as PhD students and study geriatric assessment of persons aged 70 years or more with cancer.|
We are pleased that The Danish Cancer Society has decided to support three research projects initiated by our AgeCare scientists. In one of the projects, the main purpose is to evaluate the advantages of optimizing older cancer patients general conditions before cancer treatment. In another project, essential factors that contribute to the optimal radiation therapy of older cancer patients will be identified. At last, the third project will elucidate the need for spiritual care training for older cancer patients.
|DCCC Age seminar highlights national protocols and consensus in geriatric assessments
|October 29, 2018|
We are pleased to announce that Board of Odense University Hospital has decided to extend funding of the AgeCare Elite Research Center for the period 2019-2023. We are very grateful for their decision and contribution to the center, as well as the contribution of all participants to this success.
|October 29, 2018|
|Marianne Ewertz, Professor of Clinical Oncology and Head of Research, Dept. of Oncology, Odense University Hospital, and Chair of AgeCare since September 1st 2017, has decided to step down as Head of Research in Dept. of Oncology and Chair of AgeCare. We thank Marianne deeply for her great contribution with the management of the Elite center, which among many other things has resulted in the extension of funding. We are happy that Marianne Ewertz remains an active member of the center.
Professor Henrik Ditzel, who has been intimately involved in the AgeCare Elite Research Center from its beginning (and work package leader of WP2) will per October 1st 2018 succeed Marianne Ewertz as Chair of AgeCare and Head of Research in the Department of Oncology.
The Danish Comprehensive Cancer Center (DCCC) supports Trine Lembrecht Jørgensens application in establishing a national network group called DCCC AGE that will facilitate research within geriatric assessments in older cancer patients.
|September 27, 2018|
|Followup on AgeCare Symposium on August 24, 2018:|
|Selected pictures from the Symposium.
Click on a picture to view larger resolution.
|Lectures from the Symposium. Click to open as PDF in new window. Some files may be large (up to 5 MB), so please be patient.|
|Speaker||Title of lecture||Link to slides|
|Marianne Ewertz||Welcome||Open slides in PDF|
|Dorothy Keefe||Management of elderly cancer patients||Open slides in PDF|
|WP1: M.Ewertz||Trends in cancer in the elderly||Open slides in PDF|
|WP1: H.Frederiksen||Lymphomas and other haematological cancers in the elderly||Open slides in PDF|
|Martin Villumsen||Late Effects of Cancer and Cancer-Treatment in Danish Twins and Singletons||Open slides in PDF|
|WP2: H.Ditzel||Cancer biology and molecular biomarkers in elderly cancer patients.||Open slides in PDF|
|Birgitte Bjørnhart||Impact of age and comorbidity on effect of treatment, adverse effects and Quality of Life in lung cancer patients receiving immunotherapy||Open slides in PDF|
|Marianne Vogsen||Adherence to treatment guidelines and survival in women with early-stage breast cancer aged 70 years or more in Denmark||Open slides in PDF|
|Ricardo Audisio||How to improve surgical outcomes for older cancer patients||Open slides in PDF|
|WP3: L.Lund||Liquid biopsy in elderly men with prostate cancer||Open slides in PDF|
|Mads Hvid Poulsen||Bone health and body composition changes in men treated with androgen deprivation therapy for prostate cancer||N/A|
|WP4: O. Hansen||Analyses of outcome and side effects after radiotherapy in the elderly patients with localized or locally advanced NSCLC||Open slides in PDF|
|Stefan S. Jeppesen||Impact of comprehensive geriatric assessment in patients with non-small cell lung cancer treated with stereotactic body radiotherapy.||Open slides in PDF|
|Rana Bahij||Overall survival in elderly patients with SCLC||Open slides in PDF|
|WP5: P.Pfeiffer||Treatment of elderly patients with colorectal cancer||Open slides in PDF|
|Stine B. Winther||NORDIC9: A randomized phase II trial evaluating first line treatment strategy in older and frail patients with metastatic colorectal cancer||Open slides in PDF|
|WP5: N.Abildgaard||Treatment of geriatric haematological cancer; from clinical trials to daily clinic – and vice-versa||N/A|
|CØ. Svendsen||Video consulted patient rounds at a Haematological Ward – experiences from relatives||Open slides in PDF|
|WP6: Trine L. Jørgensen||Polypharmacy, potential inappropriate medications, and drug interactions in older patients with ovarian cancer||N/A|
|Sambavy Nadaraja||Significance of Geriatric Assessment for Optimal Treatment of Older Cancer Patients||Open slides in PDF|
|WP7: N.C.Hvidt||Existential and spiritual needs of older cancer patients||Open slides in PDF|
|WP7: K.Dieperink||Adverse effects and supportive care for radiated prostate cancer patients and partner. A review of studies in AgeCare.||Open slides in PDF|
|NI Andersen||Caregivers and Cancer. A Participatory Design Study||N/A|
|March 7, 2018|
|August 23, 2018|
|Professor of Clinical Oncology, Jørn Herrstedt, leaves his position as Chair of AgeCare and Head of Research at Odense University Hospital per September 1st 2017 due to a new position as Head of Research in Oncology, Region of Zealand. Jørn Herrstedt will continue as co-chair of WP6.
Marianne Ewertz, Professor of Clinical Oncology, has been appointed Head of Research, Dept. of Oncology, Odense University Hospital, and Chair of AgeCare per September 1st 2017.
|November 27, 2016|
|November 21, 2016|
|Former General Manager Line Haslund has (after excellent work for AgeCare) decided to stop in order to devote herself to the work of the Clinical Research Unit at the Department of Oncology at full time.
It is our pleasure to announce that Christina Nordenbæk has been appointed General Manager of AgeCare per November 1st 2016. Christina has been a full time Project Coordinator also at the Clinical Research Unit at the Department of Oncology.
|May 3, 2016|
|We are proud to announce that the Academy of Geriatric Cancer Research in collaboration with the Danish Cancer Society will be hosting the symposium ” Cancer in the elderly”.
The Symposium will take place from the 7-9 November 2016 in Copenhagen and the faculty will include national and international speakers.
The symposium will uncover the topic “Cancer in the elderly” from basic research through translational research and also focus on implementation into clinical practice.
Participation is free of charge, but only a maximum of 40 participants will be selected based on approval of an abstract. Applicants should submit an abstract summarizing one or more research projects in the area.
The focus group is PhD students, Post Docs and senior scientist from the Danish research environment.
Participants must apply the Danish Cancer Society.
For more information see www.cancer.dk/symposium
|August 31, 2015|
|AgeCare was officially nominated an Elite Research Center at Odense University Hospital, December 2013, and work was initiated January 2014. The 5-year research plan was evaluated by an Assessment Committee including eight international top scientist and will be reviewed on an annual basis by an international Advisory Board. The research plan is divided into seven work packages focusing on cancer epidemiology, biomarkers, surgery, radiotherapy, medical cancer treatment and supportive care (e.g. comorbidity, polypharmacy and rehabilitation) in older cancer patients (AgeCare Project). AgeCare consists of 70 researches from different cancer-related disciplines. A Steering Committee includes all work package leaders and the General Manager (AgeCare Team) and will convene twice a year and ad hoc. The Steering Committee will guide the overall strategy and national and international collaboration. AgeCare will strive for cooperation with other groups and societies in the field e.g. the Cancer and Aging Research Group (CARG) and the International Society for Geriatric Oncology (SIOG) and there are several members from these groups among the 18 international members of AgeCare. (AgeCare Team). AgeCare plans to initiate 17 PhD courses (3-year positions) and 10 post doc courses (3-year 50% positions) over the period of 2014 to 2018. Apart from the 17 PhD degrees, this should eventually result in 80-90 peer-reviewed publications in international journals in five years. As of September 2015, 8 PhD courses and 2 post doc positions have been initiated (see initiated projects below). Publications from the first AgeCare related trials are listed on this web site (Publications). AgeCare will receive funding from Odense University Hospital (14 mill DKK over the period of 2014 to 2018) and is committed to seek funding for the rest of the 50 mill DKK budget. So far the Danish Cancer Society, Velux Foundation, Odense University Hospital Research Council and the University of Southern Denmark have contributed. Please contact one of us, if you are interested in cooperating with AgeCare.|
|Christina Nordenbæk||Marianne Ewertz MD, DMSc|
|General Manager||Head of AgeCare|